Atlas Trials

Dose Escalation, MTD, Safety and PK Study of a Single Dose SC Injection of TransCon PEG Treprostinil in Healthy Male Volunteers

Clinical trial NCT02149095 · WITHDRAWN

Trial details

NCT number
NCT02149095
Sponsor
United Therapeutics
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
PAH
Start date
2014-07-01
Primary completion
2014-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.